Historical benchmarks for medical therapy trials in surgery-and radiation-refractory meningioma: a RANO review
T Kaley, I Barani, M Chamberlain, M McDermott… - Neuro …, 2014 - academic.oup.com
Background The outcomes of patients with surgery-and radiation-refractory meningiomas
treated with medical therapies are poorly defined. Published reports are limited by small …
treated with medical therapies are poorly defined. Published reports are limited by small …
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
L Rogers, I Barani, M Chamberlain, TJ Kaley… - Journal of …, 2015 - thejns.org
Evolving interest in meningioma, the most common primary brain tumor, has refined
contemporary management of these tumors. Problematic, however, is the paucity of …
contemporary management of these tumors. Problematic, however, is the paucity of …
Emerging systemic treatment options in meningioma
Purpose Meningiomas are the most frequently diagnosed intracranial neoplasms. Usually,
they are treated by surgical resection in curative intent. Radiotherapy and stereotactic …
they are treated by surgical resection in curative intent. Radiotherapy and stereotactic …
Current treatment options for meningioma
C Apra, M Peyre, M Kalamarides - Expert review of …, 2018 - Taylor & Francis
Introduction: With an annual incidence of 5/100,000, meningioma is the most frequent
primary tumor of the central nervous system. Risk factors are radiotherapy and hormone …
primary tumor of the central nervous system. Risk factors are radiotherapy and hormone …
EANO guideline on the diagnosis and management of meningiomas
R Goldbrunner, P Stavrinou, MD Jenkinson… - Neuro …, 2021 - academic.oup.com
Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials
have been conducted to guide clinical decision making, resulting in variations of …
have been conducted to guide clinical decision making, resulting in variations of …
An overview of managements in meningiomas
L Zhao, W Zhao, Y Hou, C Wen, J Wang, P Wu… - Frontiers in …, 2020 - frontiersin.org
Meningioma is the most frequent primary tumor of the central nervous system. Important
advances have been achieved in the treatment of meningioma in recent decades. Although …
advances have been achieved in the treatment of meningioma in recent decades. Although …
Meningiomas: updating basic science, management, and outcome
KJ Drummond, JJ Zhu, PML Black - The neurologist, 2004 - journals.lww.com
Background: Meningiomas are biologically complex and clinically and surgically
challenging. These features, combined with the rewarding potential for cure, make them of …
challenging. These features, combined with the rewarding potential for cure, make them of …
Advances in multidisciplinary therapy for meningiomas
PK Brastianos, E Galanis, N Butowski, JW Chan… - Neuro …, 2019 - academic.oup.com
Surgery has long been established as the first-line treatment for the majority of symptomatic
and enlarging meningiomas, and evidence for its success is derived from retrospective case …
and enlarging meningiomas, and evidence for its success is derived from retrospective case …
Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution
LA Rosenberg, RA Prayson, J Lee, C Reddy… - International Journal of …, 2009 - Elsevier
PURPOSE: To evaluate the outcomes for patients with Grade III meningiomas as defined by
the 2007 World Health Organization standards. METHODS AND MATERIALS: The slides …
the 2007 World Health Organization standards. METHODS AND MATERIALS: The slides …
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group
No standard criteria exist for assessing response and progression in clinical trials involving
patients with meningioma, and there is no consensus on the optimal endpoints for trials …
patients with meningioma, and there is no consensus on the optimal endpoints for trials …